The Full Wiki

More info on TGF beta 3

TGF beta 3: Wikis

Advertisements

Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.

Encyclopedia

From Wikipedia, the free encyclopedia

TGF beta 3
Identifiers
Symbol TGFB3
Entrez 7043
HUGO 11769
OMIM 190230
RefSeq NM_003239
Other data
Locus Chr. 14 q24

Transforming growth factor beta 3 (TGF-β3) is a type of protein, known as a cytokine, which is involved in cell differentiation, embryogenesis and development. It belongs to a large family of cytokines called the Transforming growth factor beta superfamily, which includes the TGF-β family, Bone morphogenetic proteins (BMPs), growth and differentiation factors (GDFs), inhibins and activins.[1]

TGF-β3 is believed to regulate molecules involved in cellular adhesion and extracellular matrix (ECM) formation during the process of palate development. Without TGF-β3, mammals develop a deformity known as a cleft palate.[2][3] This is caused by failure of epithelial cells in both sides of the developing palate to fuse. TGF-β3 also plays an essential role in controlling the development of lungs in mammals, by also regulating cell adhesion and ECM formation in this tissue,[4] and controls wound healing by regulating the movements of epidermal and dermal cells in injured skin.[5]

Clinical research

As of April 2009, human recombinant TGF-β3 (Avotermin, planned trade name Juvista) is undergoing clinical phase I/II trials for the improvement of skin scarring.[6]

References

  1. ^ Herpin A, Lelong C, Favrel P (2004). "Transforming growth factor-beta-related proteins: an ancestral and widespread superfamily of cytokines in metazoans". Dev Comp Immunol 28 (5): 461–85. doi:10.1016/j.dci.2003.09.007. PMID 15062644.  
  2. ^ Taya Y, O'Kane S, Ferguson M (1999). "Pathogenesis of cleft palate in TGF-beta3 knockout mice". Development 126 (17): 3869–79. PMID 10433915.  
  3. ^ Dudas M, Nagy A, Laping N, Moustakas A, Kaartinen V (2004). "Tgf-beta3-induced palatal fusion is mediated by Alk-5/Smad pathway". Dev Biol 266 (1): 96–108. doi:10.1016/j.ydbio.2003.10.007. PMID 14729481.  
  4. ^ Kaartinen V, Voncken J, Shuler C, Warburton D, Bu D, Heisterkamp N, Groffen J (1995). "Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction". Nat Genet 11 (4): 415–21. doi:10.1038/ng1295-415. PMID 7493022.  
  5. ^ Bandyopadhyay B, Fan J, Guan S, Li Y, Chen M, Woodley DT, Li W (2006). "A "traffic control" role for TGFbeta3: orchestrating dermal and epidermal cell motility during wound healing". J Cell Biol. 172 (7): 1093–105. doi:10.1083/jcb.200507111. PMID 16549496.  
  6. ^ Ferguson, Mark (11 April 2009). "Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies". Lancet 373 (9671): 1264–1274. doi:10.1016/S0140-6736(09)60322-6. http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)60322-6/abstract.  
Advertisements

Advertisements






Got something to say? Make a comment.
Your name
Your email address
Message